Sanofi SA added a new plant in Singapore to make vaccines and other medicines, as the French pharmaceutical group seeks to ...

SINGAPORE — French pharmaceutical giant Sanofi on Wednesday opened a 800 million Singapore dollar ($595 million) "evolutive ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be ...

Sanofi's $595m Singapore facility, Modulus, leverages advanced technology for rapid, flexible vaccine production, bolstering ...

French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...

The 58,000 sq m plant – Sanofi’s second factory in Singapore – will produce vaccines and other biopharmaceutical products ...

The facility, named Modulus, can be adapted to manufacture up to four vaccines or biopharmaceuticals at the same time, and ...

About 200 people with the condition will be recruited for the trial, which will start in 2025. Read more at straitstimes.com.